Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification
Consult the results of the study published in the EuroIntervention Journal by Y. Maeno et al.
The impact of left ventricular outflow tract calcification (LVOT-CA) on SAPIEN 3 transcatheter aortic valve replacement (S3-TAVR) is not well understood. The aims of the present study were to determine optimal device sizing for S3-TAVR in patients with or without LVOT-CA and to evaluate the influence of residual paravalvular leak (PVL) on survival after S3-TAVR in these patients.
Maeno Y, Abramowitz Y, Jilaihawi H, Israr S, Yoon S, Sharma RP, Kazuno Y, Kawamori H, Miyasaka M, Rami T, Mangat G, Takahashi N, Okuyama K, Kashif M, Chakravarty T, Nakamura M, Cheng W, Makkar RR.